← Leaderboards
B Hildreth
Medical University Of South Carolina
$0
Attributed
$0
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 4
By mechanism
M01$0 · 4
Top collaborators
No co-investigators on record.
Most similar at Medical University Of South Carolina
Same institution · by research overlap
- Crystal A. Gadegbeku$5,788,715
- Norman H Bell$1,281,695
- Gary S. Gilkeson$15,374,032
- Lyndon L Key$25,066
- W A Brzezinski$0
Others in their field
Top investigators on “Drug Screening /Evaluation”
- Fred M Gordin · Social And Scientific Systems, Inc.$68,001,399
- John C S Breitner · Johns Hopkins University$33,065,187
- Philip J Disaia · University Of California Irvine$21,551,991
- George R Painter · Chimerix, Inc.$19,230,662
- Gregory H Reaman · National Childhood Cancer Foundation$17,052,970
- Stephen J Durako · Westat, Inc.$15,048,684
Research focus
Drug Screening /EvaluationOsteoporosisClinical ResearchHuman SubjectHuman Therapy EvaluationSkeletal Disorder ChemotherapyFemaleDrug Adverse EffectLongitudinal Human StudyBone DensityWomen'S HealthPostmenopauseAlendronateBone FractureBone MetabolismPlacebosKidney FunctionOral AdministrationIntravenous AdministrationPathologic Bone ResorptionDrug Administration Rate /DurationInhibitor /AntagonistMaleEstrogen Inhibitor
Grant awards (16)
RALOXIFENE HCL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2002 · RR
ALENDRONATE TRIAL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2002 · RR
IBANDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2002 · RR
ALENDRONATE SODIUM FOR OSTEOPOROSIS IN MEN$0
M01 · FY2002 · RR
ALENDRONATE TRIAL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE TRIAL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
IBANDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
IBANDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
RALOXIFENE HCL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE SODIUM FOR OSTEOPOROSIS IN MEN$0
M01 · FY2001 · RR
ALENDRONATE SODIUM FOR OSTEOPOROSIS IN MEN$0
M01 · FY2001 · RR
ALENDRONATE SODIUM FOR OSTEOPOROSIS IN MEN$0
M01 · FY2001 · RR
IBANDRONATE IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
RALOXIFENE HCL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
RALOXIFENE HCL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR
ALENDRONATE TRIAL IN POSTMENOPAUSAL OSTEOPOROSIS$0
M01 · FY2001 · RR